Ginkgo Bioworks reported its 2021 financials Thursday, and the $1.7 billion of stock-based compensation caught everyone’s attention. In particular, two of the company’s executives, Jason Kelly, chief executive officer, and Reshma Shetty, chief operations officer, each received more than $364 million in compensation, although it was mostly in stock.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,